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Trends
Candida albicans is the main cause of
candidiasis, however, non-C. albicans
Candida species are now frequently
identiﬁed as potential human pathogens.
Bioﬁlm formation is a potent virulence
factor for a number of Candida spe-
cies, as it confers signiﬁcant resistance
to traditional antifungal therapy.Review
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Most cases of candidiasis have been attributed to Candida albicans, but
Candida glabrata, Candida parapsilosis and Candida tropicalis, designated
as non-C. albicans Candida (NCAC), have been identiﬁed as frequent human
pathogens. Moreover, Candida bioﬁlms are an escalating clinical problem
associated with signiﬁcant rates of mortality. Bioﬁlms have distinct develop-
mental phases, including adhesion/colonisation, maturation and dispersal, con-
trolled by complex regulatory networks. This review discusses recent advances
regarding Candida species bioﬁlm regulatory network genes, which are key
components for candidiasis.There are common genetic require-
ments for bioﬁlm formation; however,
much work is needed to complete the
picture of bioﬁlm regulatory network
genes.
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Of the fungi regarded as human pathogens, members of the genus Candida are the most
frequently recovered from fungal infections and these Candida infections are collectively
referred to as candidiasis. The genus Candida is an extremely heterogeneous group of over
150 species, but it is well established that only a few of these are implicated in human
infectious diseases [1]. Furthermore, it is clear that fungal infections have emerged as
important public health problems and candidiasis has been associated with high morbidity
and mortality [1].
Candida species normally exist as commensals, but they are opportunistic pathogens with
the ability to cause superﬁcial and systemic infections [2]. The prevalence of opportunistic
Candida infections has dramatically increased over recent decades, and this is particularly
evident in immunocompromised individuals [3]. Although most of the cases of candidiasis
have been attributed to C. albicans, in recent decades improved diagnostic methods
and higher levels of resistance to certain antifungals [4] have led to the appearance of
NCAC species, particularly C. glabrata, C. parapsilosis, and C. tropicalis [5]. Moreover, the
pathogenicity of Candida species is facilitated by a number of virulence factors, including
dimorphism, secretion of hydrolytic enzymes (such as proteases, lipases, and haemolysins)
and the ability to adhere and form bioﬁlm on medical devices and/or the host mucosal
epithelium [6].
It is assumed that one of the major contributions to Candida species virulence is its versatility to
adapt to a variety of different habitats and the formation of surface-attached microbial commu-
nities, known as bioﬁlms [5]. Bioﬁlm development by Candida species is a fascinatingly intricate
process involving ﬁne alterations in gene expression, requiring complex and well coordinated
regulation to accomplish the process with high efﬁciency, both spatially and temporally. Thus,
this review examines recent advances about the regulators of bioﬁlm network genes in Candida
species that are key components of candidiasis.62 Trends in Microbiology, January 2017, Vol. 25, No. 1 http://dx.doi.org/10.1016/j.tim.2016.09.004
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Bioﬁlm Formation by Candida Species
Bioﬁlms are communities of microorganisms properly organized and embedded in an extracel-
lular matrix [7]. This mode of growth is a potent virulence factor for all Candida species.
Moreover, C. albicans, C. parapsilosis, C. tropicalis and C. glabrata isolates are good bioﬁlm
formers, and the presence of bioﬁlms during infection has been related to higher morbidity and
mortality rates compared to isolates incapable of forming bioﬁlms [8].
Bioﬁlm formation is a sequential phenomenon which involves attachment, maturation, and
detachment [9], as illustrated in Figure 1. Attachment and colonisation of yeast cells to an
abiotic or/and biotic surface is the ﬁrst step of bioﬁlm development (Figure 1A). Initial attachment
of Candida cells is followed by cell division, this proliferation leading to the formation of a basal
layer of anchoring microcolonies [9,10] (Figure 1B), and then subsequent bioﬁlm maturation
(Figure 1C). The bioﬁlm maturation is, generally, characterized by the presence of ﬁlamentousKey:
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Figure 1. Regulatory Network Genes for the Different Bioﬁlm Stages of Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida
glabrata. (A) Initial adhesion. (B) Formation of basal microcolony layers. (C) Mature bioﬁlm constituted by cells with diverse morphologies and extracellular matrix. (D)
Bioﬁlm detachment and dispersion.
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Figure 2. Bioﬁlm Structure of Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida
glabrata. Filamentous forms (hyphae or pseudohyphae). Blastospores. Images obtained with scanning electron micro-
scopy after 24 h of bioﬁlm growth.forms, pseudohyphae and/or hyphae, and by the production of extracellular matrix [10,11]. The
role of the matrix is to protect Candida cells from phagocytic cells and to act as a barrier to drugs
and toxic substances [12,13]. Moreover, this matrix allows the maintenance of nutrients within it
to reach bioﬁlm cells [12,13]. Finally, mature bioﬁlms have the ability to initiate detachment and
dispersion (Figure 1D) on their own. Furthermore, this release of cells from the original bioﬁlm
community is a step forward in generating novel communities at new locations [14].
It is important to address the fact that bioﬁlms are variable in their structure and matrix
composition, differing between species and strains [15] (Figure 2 and Table 1). In the caseTable 1. Bioﬁlm Characteristics of Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida
glabrata
Species Bioﬁlm Structure Matrix Composition Refs
C. albicans Bilayer structure with yeast, hyphae,
and pseudohyphae
Mainly composed by carbohydrates,
proteins, phosphorus, and
hexosamines
[3,11,12,14,73,74]
C. parapsilosis Thin bioﬁlm consisting of aggregated
blastospores with yeast cells and
pseudohyphae
High quantities of carbohydrates and
low levels of proteins
[4,74–77]
C. tropicalis Dense network of yeast cells with
evident ﬁlamentous morphologies
Low levels of carbohydrates and
proteins
[4,7,11,74]
C. glabrata Compact monolayer or multilayer
of only blastospores
High levels of carbohydrates and
proteins; mainly composed of
hexosamine
[5,7,11,74]
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of C. albicans, the bioﬁlm structure normally consists of two layers, a basal deposit of blas-
tospores covered by a thick matrix ﬁlm with hyphal forms (Figure 2). Furthermore, bioﬁlm
formation in this species is related to the transition from yeast to hyphal growth, as mentioned
above [14]. Compared to C. albicans, bioﬁlms of C. parapsilosis are much less thick, consisting
of aggregated blastospores with yeast cells and pseudohyphae [4] (Figure 2). In the case of C.
tropicalis, mature bioﬁlms are usually characterised by a dense network of yeast cells with
evident ﬁlamentous morphologies. In contrast to this species (Figure 2), C. glabrata bioﬁlms are
characterised by a compact monolayer or multilayer with only blastospores, since this species is
unable to form ﬁlamentous forms (Figure 2) [5].
Table 1 summarizes the general characteristics of the four most important pathogenic Candida
species. Carbohydrates, proteins, phosphorus, and hexosamines are the major constituents of
the bioﬁlm matrix of C. albicans [12,16]. In the case of C. parapsilosis, Silva et al. [7] reported that
the extracellular matrices contain high quantities of carbohydrates; however, the quantity of
protein is lower compared with that of other species. The matrices of C. glabrata and C. tropicalis
are also composed of proteins and carbohydrates [5], but C. glabrata has higher levels as
compared to C. tropicalis [7].
Regulatory Network Genes for the Different Bioﬁlm Phases of Candida
Species
Mucosal infections could be associated with bioﬁlms in that the pathogen adheres to a surface
and produces an extracellular matrix [17]. This relationship has prompted investigations to test
the hypothesis that genes required for bioﬁlm formation in vitro may be required for mucosal
infection as well. Findings from these studies have underscored the utility of this perspective in
that there are several common genetic requirements for the formation and development of
bioﬁlms on abiotic and mucosal surfaces [9]. The distinct developmental phases of bioﬁlms
(adhesion/colonisation, maturation, and dispersal) are directed by complex molecular events.
Bioﬁlm formation is strongly dependent on environmental conditions, which makes the com-
parison of regulatory genetic alterations among Candida species not easy. It should also be
noted that the whole genome is only known for C. albicans and C. glabrata. Despite that,
the currently known regulatory network of genes involved in bioﬁlm formation for C. albicans,
C. parapsilosis, C. glabrata, and C. tropicalis are described and compared below and summa-
rized in Table 2.
Adherence and/or Colonisation
Adherence of Candida cells to mucosal surfaces and/or synthetic material is an early step
leading to proliferation and consequently bioﬁlm formation and infection (Figure 1) [4]. The
adhesion mechanism is based on interaction between the cell wall of the microorganism and cell
surfaces of the host. Thereby, adherence is mediated by host cells, fungal cells, and environ-
mental conditions [18]. Modulation of the adhesion process can be achieved by microbial
adhesins or host cell receptors, or by physical and chemical manipulations [19].
The presence of speciﬁc cell-wall proteins, designated normally as adhesins, is a trigger in the
modulation of the adhesion process [5]. In C. albicans, the adhesion is mediated by agglutinin-
like sequence (Als) proteins (Figure 1) [6]. The family of Als adhesins in C. albicans consists
in eight members, namely Als1–7 and 9, and all proteins have a similar structure containing an
N-terminal secretory signal sequence [6]. Speciﬁcally, Als1 and Als3 proteins are involved in
bioﬁlm surface attachment; however, their expression differs depending on C. albicans cell
morphology [20]. In the case of ALS1, expression is detectable in both yeast and hyphal
cell morphology [21], but ALS3 is expressed only in the hyphal lifestyle [22]. Of the eight
ALS genes, ALS1, ALS3, and ALS5 are reported to be involved in the adhesion of C. albicans
to a variety of biotic substrates [23].Trends in Microbiology, January 2017, Vol. 25, No. 1 65
Table 2. Genes Involved in Genetic Control of Adherence and Bioﬁlm Formation in Candida albicans
Candida parapsilosis, and Candida glabrata Species
Species Systematic
Name
Gene
Name
Description Refs
C. albicans Adhesion
and/or
colonisation
Orf19.5741/
Orf19.1816
ALS1/
ALS3
Cell-wall protein adhesin;
involved in adherence to
vascular endothelial cells and
oral epithelial cells
[35,78,79]
Orf19.5736 ALS5 Cell-wall protein involved in
adherence process
[78,79]
Orf19.1321 HWP1 Cell-wall adhesin; involved in
adhesion step: promotes
physical contact between
epithelial cells and the fungal
cells
[25,27,80]
Orf19.1401 EAP1 GPI-linked cell wall protein;
involved in the cell–cell adhesion
[10,21,
24,73]
Orf19.5674 PGA10 GPI membrane protein; involved
in full adherence and essential for
bioﬁlm development
[10,29,81]
Orf19.6274 PBR1 White cell / factor-induced
gene; full adherence
[10,28,82]
Orf.19.4477 CSH1 White cell / factor-induced
gene; full adherence of bioﬁlm
[10,28,82]
Orf19.3127 CZF1 Transcription factor; required for
yeast adherence to silicone
[50]
Maturation Orf19.1321 HWP1 Hyphal cell-wall mannoprotein;
required for hyphal formation
[23,25,27,
80,83,84]
Orf19.723 BCR1 Transcription factor required for
bioﬁlm formation; involved in the
early adhesion stage
[17,38,
73,76]
Orf19.610 EFG1 Transcription factor of bioﬁlm
formation; Involved in cell
surface, adhesion and hyphal
formation
[9,38,43,
85–87]
Orf19.5908 TEC1 Transcription factor required for
bioﬁlm formation; required for
hyphal formation
[38,40,44,
46,73,82]
Orf19.2119 NDT80 Transcription factor of bioﬁlm
formation; involved in hyphal
development
[9,40]
Orf19.4998 ROB1 Transcription factor of bioﬁlm
formation
[6,9]
Orf19.4056 BRG1 Transcription factor of bioﬁlm
formation
[6,9]
Orf19.1822 UME6 Transcription regulator of yeast–
ﬁlament transition
[40,72,88]
Orf19.1187 CPH2 Transcription factor; promotes
hyphal growth
[51]
Orf19.6124 ACE2 Involved in regulation of bioﬁlm
development
[48]
Orf19.3794 ZAP1 Negative regulator of bioﬁlm
matrix production; high levels of
b-1,3 glucan both in vitro as in
vivo in Dzap1/zap1
[6,10,
56,89]
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Table 2. (continued)
Species Systematic
Name
Gene
Name
Description Refs
Orf19.5101 CCR4 Negative regulator of bioﬁlm
matrix production; over-
production of extracellular matrix
in Dccr4/ccr4
[61]
Orf.19.2929 FKS1 b-1,3 glucan synthase; bioﬁlm
resistance to ﬂuconazole via a
role in b-1,3 glucan levels in the
extracellular matrix
[10,54,
55,57]
Orf.19.4477 CSH1 Cell-matrix adhesion; negative
regulator of matrix production
when ZAP1 is activated
[10,56]
Orf.19.1048 IFD6 Negative regulator of matrix
production when ZAP1 is
activated
[10,56]
Orf.19.4899 GCA1 Positive regulator of matrix
production when ZAP1 is
activated
[10,56]
Orf.19.999 GCA2 Positive regulator of matrix
production when ZAP1 is
activated
[10,56]
Orf.19.2608 ADH5 Positive regulator of matrix
production when ZAP1 is
activated
[10,56]
Orf.19.4662 RLM1 Putative transcription factor;
positive regulator of matrix
production
[57,89]
Orf.19.4565 BGL2 Cell wall 1,3-beta-
glucanosyltransferase; involved
in matrix delivery
[6,55,60]
Orf.19.3829 PHR1 Glucanosyltransferase; involved
in matrix delivery
[55,59]
Orf.19.2990 XOG1 b-1,3 exoglucanase involved in
matrix delivery
[6,55,58]
Dispersion Orf19.7150 NRG1 Transcription factor;
overexpression increases
released cells; negative regulator
of ﬁlamentation
[10,44,
69–72,88]
Orf19.4093 PES1 Responsible for reverse
morphological transition (from
hyphae to yeast):
overexpression increases
released cells
[10,67,
69,90]
Orf19.1822 UME6 Transcription regulator of yeast-
ﬁlament transition;
overexpression reduces
released cells
[67,72,88,
90,91]
Orf19.6515 HSP90 Bioﬁlm azole resistance; key
regulator in bioﬁlm dispersal
[6,67,
89,92]
C. parapsilosis Attachment CPAR2_403520 HWP1 Cell adhesion; involved in
attachment step and
consequently in bioﬁlm formation
[25]
ALS1-5 Putative adhesins involved in
adhesion step
[31]
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Table 2. (continued)
Species Systematic
Name
Gene
Name
Description Refs
Maturation CPAR2_205990 BCR1 Transcription factor required for
bioﬁlm formation; when the
ortholog is deleted, the bioﬁlm
formed is thinner
[38,40,41,
73,76,93]
CPAR2_701620 EFG1 Transcription factor involved in
bioﬁlm formation and hyphal
growth
[40,43]
CPAR2_213640 NDT80 Transcription factor activity
involved in bioﬁlm formation
[40,43]
CPAR2_403510 RBT1 Required for bioﬁlm
development; regulated by
BCR1
[76,94]
CPAR2_501290 CZF1 Transcription factor of bioﬁlm
formation
[40]
CPAR2_800210 GZF3 Transcription factor of bioﬁlm
formation
[40]
CPAR2_803820 UME6 Transcription factor of bioﬁlm
formation
[40]
CPAR2_603440 CPH2 Transcription factor of bioﬁlm
formation
[40]
CPAR2_204370 ACE2 Transcription factor of bioﬁlm
formation
[40]
CPAR2_106400 FKS1 Maturation of bioﬁlm in presence
of glucose
[62]
C. tropicalis Attachment ALS1-16 Putative adhesins involved in
adhesion step of bioﬁlm
formation
[31]
Maturation EFG1 Filamentation, bioﬁlm formation
and white-opaque switching
[45]
C. glabrata Attachment CAGL0E06644g EPA1 Cell adhesion molecule; epithelial
adhesin involved in adherence to
host surface
[5,23,
32–34]
CAGL0C00110g/
CAGL0C05643g
EPA6/
EPA7
Epithelial adhesin involved in
adherence to host surface
[32,35,95]
CAGL0J02508g/
CAGL0K00110g
AWP1/
AWP2
Adhesin-like wall protein [36,37,96]
CAGL0J11891g AWP3 Putative adhesin-like wall protein [36,37,96]
CAGL0J11990g AWP4 Adhesin-like wall protein [36,37,96]
CAGL0K13024g/
CAGL0G10175g
AWP5/
AWP6
Adhesin-like wall protein [37,96]
CAGL0C00209g AWP7 Putative adhesin-like wall protein [37]
Maturation CAGL0G01034g FKS1 b-1,3 glucan synthase involved
in cell wall and extracellular
matrix
[55,63,64]
CAGL0G00286g/
CAGL0M13849g/
CAGL0F01287g
GAS1/
GAS2/
GAS5
b-1,3 glucan synthase [36,65,66]
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Eap1 is a GPI-linked (glycosylphosphatidylinositol-dependent) cell-wall protein which is involved
in cell–cell adhesion in C. albicans (Figure 1) [24]. This protein mediates surface binding; its
synthesis is regulated by the transcription factor EFG1 [21].
Hyphal wall protein I (Hwp1) is a fungal cell-wall mannoprotein that promotes attachment of
Candida cells to the host surface [23]; it was also the ﬁrst cell-surface protein described as
involved in in vivo C. albicans bioﬁlm formation (Figure 1) [25]. In the other instances, Orsi et al.
[26] demonstrated that this gene is involved in the formation of germ tubes and hyphal forms and
thus promotes physical contact between epithelial cells and the fungi, concluding that Hwp1
is an important effector of C. albicans pathogenicity [27]. This gene was extensively studied in
C. albicans; however, in the case of NCAC species little is known [25]. Despite that, Wan Harun
et al. [25] demonstrated that HWP1 mRNA was also expressed in C. parapsilosis and
C. tropicalis, but not detected in C. glabrata. The fact that HWP1 is positively expressed in
these three species during the process of adhesion and bioﬁlm formation indicates its involve-
ment in producing adhesins covalently linked to the cell-wall glucan [25].
The cell-surface protein Pga10 and the secreted Pbr1 protein are also described as important for
the full adherence of C. albicans bioﬁlms (Figure 1) [28]. Pga10, also known as RBT51, is a
member of CFEM (common in several fungal extracellular membranes) proteins and has a role in
adhesion in C. albicans [29]. Pérez et al. [29] demonstrated that Dpga10 forms a less consistent
bioﬁlm and contributes to early detachment from the plastic substrate, when compared to the
parental strain. Additionally, Sahni et al. [28] showed that C. albicans adhesion to blood cells was
lower when the PBR1 gene was deleted.
In C. parapsilosis, adhesion to epithelial and acrylic surfaces was associated with cell-surface
hydrophobicity. Moreover, C. parapsilosis has a greater ability than C. albicans to adhere to
buccal epithelial cells [30]. Butler et al. [31] identiﬁed ﬁve members of Als and six members of
Pga30 cell-wall proteins, though there has been no further work to understand the role of these
proteins in the process of adhesion in C. parapsilosis (Figure 1) [4,31]. In the case of C. tropicalis,
Butler et al. [31] identiﬁed 16 members of the ALS family in the genome; however, additional
conﬁrmative research is needed on their involvement in bioﬁlm development.
Similar to C. albicans, adherence of C. glabrata is mediated by epithelial adhesins (Epa) that have
a similar structure to the Als proteins [5]. The family of EPA genes are composed of 17–23 genes,
depending on the strain; however, EPA1, EPA6, and EPA7 are the most important adhesins
(Figure 1) [32]. Deletion of the EPA1 gene reduces adherence in vitro to host epithelial cells [33],
and adherence of this adhesin is inhibited in the presence of lactose [34]. Regarding the Epa6
adhesin, C. glabrata does not normally express EPA6 in vitro; however, it is expressed during
urinary infection due to low levels of nicotinic acid [35]. De Groot et al. [36] identiﬁed another
family of adhesins involved in the ﬁrst stage of C. glabrata bioﬁlm development, namely Awp
adhesins (Figure 1). Initially, four Awp adhesins (Awp1–4) were identiﬁed using liquid chroma-
tography tandem mass spectrometry [36]. A subsequent study revealed the gene expression
proﬁle of the seven Awp adhesins (Awp1–7) [37]. Expression of these adhesins is signiﬁcantly
higher in bioﬁlms when compared to planktonic cells in two different media [37].
Likewise, for C. albicans, NCAC species adhesion mechanisms indicate that the cell wall likely
plays a crucial role for colonisation and subsequent bioﬁlm formation.
Bioﬁlm Maturation
Initial attachment of Candida cells is followed by cell division and proliferation, known as bioﬁlm
development (Figure 1). The bioﬁlm formation in Candida species is regulated by several
transcription factors that play a fundamental role in various pathways, and they have anTrends in Microbiology, January 2017, Vol. 25, No. 1 69
important potential in the regulation of other genes involved in bioﬁlm formation (Table 2) [38].
Nobile et al. [9] investigated the transcriptional network and identiﬁed a set of six transcription
factors in C. albicans that play an important role in the regulation of bioﬁlm formation, namely
BCR1, EFG1, TEC1, NDT80, ROB1, and BRG1 (Figure 1) [9]. Furthermore, C. albicans bioﬁlms
are defective when any of these regulators are deleted [9]. However, in the case of NCAC
species little is known about the inﬂuence of these genes in bioﬁlm formation.
BCR1 is a C2H2 zinc-ﬁnger protein essential for bioﬁlm formation in C. albicans and in C.
parapsilosis. Moreover, this gene is essential for the expression of several cell-wall proteins in C.
albicans [38], namely Als1, Als3, and Hwp1 [23,39]. Nobile et al. [38] described that the
expression of ALS3 and HWP1 is reduced in a Dbcr1/bcr1 strain, which was decreased after
adherence to plastic, endothelial and epithelial cells [35,38]. Another study by Nobile et al. [20]
highlighted the complementary surface function between Hwp1 and Als1/3 adhesins for in vitro
and in vivo bioﬁlm formation. Moreover, Nobile et al. [39] also demonstrated that BCR1 is a
regulator of adherence but it is not involved in hyphal formation. In C. parapsilosis, the ortholog of
BCR1 is also required for bioﬁlm formation [40], and when this gene is deleted, the bioﬁlm formed
by C. parapsilosis is thinner with scant layer cells compared to a bioﬁlm formed in normal
conditions, showing that BCR1 is also required for in vivo bioﬁlm formation (Figure 1) [41]. The
CFEM family of proteins are targets of BCR1 in both species and can act as cell-surface
receptors or as adhesins [42]. However, the CFEM family has just been described in C. albicans
as having a role in bioﬁlm development [41], namely RBT5, PGA10, and CSA1 (Figure 1) [29].
In C. parapsilosis, this family consists of seven members, which include the three members of C.
albicans involved in bioﬁlm formation [41]. In contrast to C. albicans and C. parapsilosis, in
C. glabrata the function of BCR1 is unknown at the moment.
EFG1 is another transcription factor required for bioﬁlm formation that regulates the cell surface
and hyphal formation [43]. Holland et al. [40] demonstrated similar reduction in bioﬁlm for C.
albicans and C. parapsilosis when EFG1 is eliminated (Figure 1). This study conﬁrmed the
results obtained by Nobile et al. [9] for EFG1 in C. albicans. Connolly et al. [43] also veriﬁed that
deleting EFG1 reduces bioﬁlm formation in C. parapsilosis. Moreover, D efg1/efg1 strains were
unable to form hyphae in C. albicans, even when grown under hypha-inducing conditions [44].
Recently, Mancera et al. [45] identiﬁed the C. tropicalis EFG1 gene and conﬁrmed that this
transcriptional factor possessed a similar role in C. albicans (Figure 1). This gene is involved in
the regulation of ﬁlamentation and bioﬁlm formation, since deletion of both alleles is critical for
these factors [45]. Furthermore, an ortholog of EFG1 was identiﬁed in the genome of C.
tropicalis; however, its position is completely different to that of EFG1 in C. albicans [45].
Again in the case of C. glabrata, the role of this gene is unknown. It is likely that C. glabrata does
not possess a gene with a similar function in its genome since they are not polymorphic
microorganisms.
TEC1 is a gene required for hyphal formation and virulence in C. albicans [39] and is a member of
the TEA/ATTS transcription factor family [46]. The DNA-binding region is contained in 66–76
conserved amino acids in the N-terminus [47]. This gene is regulated by EFG1 [2], which is
involved in regulation of ﬁlamentous growth. In C. parapsilosis, TEC1, seems not to play the
same role as in C. albicans [39], once Holland et al. [40] did not observe a dramatic reduction in
bioﬁlm formation in the case of C. parapsilosis mutant for this gene (Figure 1). It is unclear
whether TEC1 is involved in C. glabrata bioﬁlm formation.
Other transcription factors described by Nobile et al. [9] in C. albicans bioﬁlm development,
NDT80, BRG1, and ROB1, were studied also by Holland et al. [40] in C. parapsilosis (Figure 1).
NDT80 is a key factor in response to different environmental conditions and is involved in hyphal
development and virulence in C. albicans [40]. In C. parapsilosis, NDT80 deletion results in a70 Trends in Microbiology, January 2017, Vol. 25, No. 1
signiﬁcant growth defect in bioﬁlm formation. Furthermore, deleting BRG1 does not dramatically
reduce bioﬁlms in C. parapsilosis [40], indicating that this gene is not involved in bioﬁlm formation
in this species. In C. parapsilosis there is no ortholog of the ROB1 gene [40].
Bioﬁlm development in C. parapsilosis is regulated by further transcription factors, namely CZF1,
GZF3, UME6, CPH2, and ACE2 (Figure 1) [40]. Bioﬁlm formation is dramatically reduced when
ACE2 is deleted [40]. However, this gene is also involved in regulation of bioﬁlm development in
C. albicans, controlling the adherence of this species and cell division (namely, M and early G1
phases of the cell cycle) [48]. However, when ACE2 was inactivated in C. glabrata, its ability to
cause disease increased signiﬁcantly [49]. Wätchler et al. [50] described CZF1 as a gene that
contributes to yeast adhesion in C. albicans, leading to invasion and damage in the oral cavity.
The GZF3 gene is a GATA-type transcription factor [40]; however, according to Nobile et al. [9] it
is not a key gene in bioﬁlm development in C. albicans. In this species, CPH2 promotes hyphal
growth [51] and regulates the expression of TEC1, which is a transcription factor of bioﬁlm
formation as described above [52].
The production of extracellular matrix is another important feature in bioﬁlm maturation [10]. As
described above, the composition of the matrix varies according to species, strains, and
environmental conditions, and it is well known that the main components of the matrix are
carbohydrates and proteins [11]. One of the carbohydrates present in C. albicans matrix is b-1,3
glucan [53]. However, a recent study by Zarnowski et al. [16] demonstrated that b-1,6 glucan is
also an important matrix component, and that it is highly dependent on the environmental
conditions used. The gene responsible for glucan synthase is FKS1 (Figure 1), more commonly
designated GSC1, and it has been implicated in C. albicans bioﬁlm resistance to ﬂuconazole
[53]. The susceptibility to ﬂuconazole is the result of FKS1 disruption which reduces the
deposition of b-1,3 glucan in the bioﬁlm matrix [54]. Furthermore, the increase in FKS1
transcription is coupled with a reduction in the delivery of glucan to matrix [55]. In C. albicans,
RLM1 and ZAP1 are two other regulators involved in matrix production in bioﬁlms (Figure 1). The
transcription factor ZAP1 is a negative regulator of bioﬁlm matrix production, and Dzap1/zap1
produces a bioﬁlm with high levels of b-1,3 glucan both in vitro as in vivo [56]. Some target genes
of ZAP1 are CSH1, IFD6, GCA1, GCA2, and ADH5, which modulate levels of b-1,3 glucan in the
bioﬁlm matrix (Figure 1) [56]. In the case of CSH1 and IFD6, when ZAP1 activates the expression
of these genes, the production of b-1,3 glucan decreases and therefore these genes are
considered as negative regulators of matrix production [56]. However, GCA1, GCA2, and
ADH5 are positive regulators since there is an increase in b-1,3 glucan when these genes
are activated by the ZAP1 gene [56]. Another regulator of matrix production is RLM1, a positive
regulator, whose deletion promoted a reduction in its matrix levels [57]. Taff et al. [55] described a
role for BGL2, PHR1, and XOG1 (Figure 1) as glucan-modifying genes involved in glucan delivery
and matrix incorporation. The BGL2 and PHR1 genes encode glucanosyltransferases, and
XOG1 is a b-1,3 exoglucanase [58–60]. Recently, Verma-Gaur et al. [61] identiﬁed another gene
regulator of bioﬁlm matrix production in C. albicans, CCR4. The authors [61] identiﬁed in Dccr41/
ccr4 C. albicans bioﬁlms several structural modiﬁcations with morphological changes and
overproduction of extracellular matrix. Therefore, as in the case of ZAP1, the CCR4 gene is
another negative regulator [61].
In addition, in C. parapsilosis, the gene FKS1 is involved in maturation of bioﬁlms in the presence
of glucose (Figure 1) [55]. Pereira et al. [62] demonstrated that the upregulation of FKS1 is
induced by high levels of glucose, leading to an increase in b-1,3 glucan synthesis. This glucan is
accumulated in the matrix, forming a dense and structured bioﬁlm [62]. Little is known about the
composition of the bioﬁlm matrix of C. glabrata; however, it is known that it is composed of b-1,3
glucan [4]. As in the previous species, the FKS1 gene is responsible for production of b-1,3
glucan in C. glabrata (Figure 1) [55], and echinocandins inhibit b-1,3 glucan synthase byTrends in Microbiology, January 2017, Vol. 25, No. 1 71
Outstanding Questions
Are bioﬁlm regulatory genes from
NCAC species similar to the known
bioﬁlm regulatory genes for C.
albicans?
What are the signal transduction path-
ways that regulate bioﬁlm formation in
Candida species?
Given the variability of the Candida spe-
cies genome, what effect does this
exert on bioﬁlm formation?targeting FKS subunits [63,64]. The GAS gene family is another regulator in the production of b-
1,3 glucan in this species [36]. Similarly to Saccharomyces cerevisiae, GAS1, GAS2, and GAS5
are a glycosylphosphatidylinositol (GPI)-anchored cell-surface proteins [65] which are involved in
the production of b-1,3 glucan in C. glabrata (Figure 1) [66].
Bioﬁlm Detachment and Dispersion
The last step is characterized by dispersal of yeast cells and/or pieces of the bioﬁlm from its
mature form; this allows the organism to colonize new sites for further adherence and coloniza-
tion [9], completing the bioﬁlm life cycle (Figure 1). Bioﬁlm dispersion occurs in response to
environmental changes, such as a decrease in, or lack of, nutrients or other modiﬁcations in the
growth media composition [67]. Furthermore, the dispersion of bioﬁlm cells can lead to a
development of infections in deep organs due to the ability to invade the bloodstream [67].
In the past decade, early events associated with Candida bioﬁlm formation have received
considerable attention. However, very little is known about Candida bioﬁlm dispersion or the
mechanisms and genes that trigger it.
Recent studies on C. albicans bioﬁlms have reported that the majority of dispersed cells are
yeast cells and that there are three regulatory genes in this step, namely, PES1, UME6, and
NRG1 (Figure 1) [10]. Uppuluri et al. [67] demonstrated that the major yeast cells dispersed from
bioﬁlm were released from the upper hyphal layers. Furthermore, overexpression of PES1 results
in an increase of yeast growth when cells were grown on medium without doxycycline (DOX)
[68]. By contrast, when NRG1 was overexpressed, in the absence of DOX, the bioﬁlm contained
only a monolayer of yeast and pseudohyphae cells [69] since NRG1 is a negative regulator of
ﬁlamentation [70,71]. UME6 is a transcription regulator of yeast–ﬁlament transition in C. albicans,
and more precisely it is required for hyphal extension (Figure 1) [72]. When UME6 was deleted,
there was a little reduction in the C. albicans bioﬁlm [40], which means that this gene has a minor
role in bioﬁlm development.
Summarizing, despite all Candida species having some similar regulatory genes in each stage of
bioﬁlm formation, there is a lack of information concerning NCAC species, which makes a
comparison among them difﬁcult. However, it is possible to stress that the ALS genes are
involved in the adhesion process of the three Candida species (C. albicans, C. parapsilosis, and
C. tropicalis), and that in C. glabrata this phenomenon is regulated by the Epas, which have a
similar structure to the Als proteins. Additionally, some transcription factors described as
involved in C. albicans bioﬁlm formation (BCR1, EFG1, and HWP1) are the same as those
implicated in C. parapsilosis bioﬁlms. C. glabrata is the species that presents more contrasts in
relation to the other Candida species, reﬂecting its genetic distance.
However, despite all our knowledge about C. albicans bioﬁlm regulators, little is known about
their involvement in other NCAC species, and thus much more research must be conducted in
order to increase our knowledge in this area.
Concluding Remarks
Bioﬁlms are communities of microorganisms embedded in an extracellular matrix, and bioﬁlms
are assumed to be the most important virulence factors for pathogenicity in Candida species.
These species utilize several genes that are conﬁrmed to play an important role in the different
stages of bioﬁlm development. Indeed, additional and comparative genomic (genome sequenc-
ing) and transcriptomic approaches (RNA seq and/or microarrays) are needed to deepen our
knowledge about the real bioﬁlm regulatory network genes, speciﬁcally in the case of NCAC
species (see Outstanding Questions). Therefore, further studies in this area will contribute
towards the identiﬁcation of new targets to be used to design new nanodrugs against these
emerging pathogens.72 Trends in Microbiology, January 2017, Vol. 25, No. 1
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